Susceptibility Testing of GSK656 against Species.
Antimicrobial agents and chemotherapy • Vol. 64, Issue 2 • 2020
First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.
Antimicrobial agents and chemotherapy • Vol. 63, Issue 8 • 2019
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
Journal of medicinal chemistry • Vol. 60, Issue 19 • 2017